Market Overview:
The global meropenem API market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented on the basis of type, application and region. On the basis of type, the market is segmented into crude meropenem and injection grade meropenem. Crude meropenem held the largest share in 2017 owing to its low cost as compared to other grades of meropenem. However, injection grade meropenem is projected to grow at a higher CAGR during the forecast period as it offers better quality and purity than crude Meropenem. On the basis of application, intravenous injection held majority share in 2017 owing to its wide usage for treatment purposes across various applications such as sepsis, pneumonia etc.
Product Definition:
Meropenem API is a carbapenem antibiotic that is used to treat a variety of infections. It works by killing the bacteria that are causing the infection. Meropenem API is important because it can help to treat a variety of infections, including those that are resistant to other antibiotics.
Crude Meropenem:
Crude meropenem is a semi-synthetic version of the antibiotic Meropenem. It’s an antibiotic used to treat bacterial infections in various parts of the body, including urinary tract, respiratory tract, and bloodstream. Crude meropenem is manufactured by chemical synthesis and has no commercial production or supply anywhere in the world.
Injection Grade Meropenem:
Meropenem is an antibiotic drug and it's used for treatment of bacterial infections in various parts of the body. The drug works by killing the bacteria that causes infection. It does not affect healthy cells and is therefore, considered as a last-resort medication to be used only after other antibiotics have been ineffective in controlling an infection.
Application Insights:
Based on the application, the global meropenem API market is segmented into intravenous injection, intramuscular injection and oral administration. The intravenous injection held the largest share in 2017 owing to its wide usage as a general anesthetic agent for surgical procedures. It also has a high therapeutic index and is well-tolerated by patients, which are some of the factors driving its demand in this segment.
The intramuscular injections are widely used for treatment of severe infections that cannot be treated by other means or when direct contact with infected tissues is anticipated during therapy. This includes osteomyelitis, meningitis and sepsis due to S pneumoniae or E coli strains; however, it should be noted that there are limited data regarding their use in these cases due to lack of clinical trials performed so far.
Regional Analysis:
North America dominated the global meropenem API market in 2017. The rising incidence of multi-drug resistant tuberculosis is one of the major factors responsible for this trend. According to WHO, around 9,000 new cases were reported in 2016 in U.S., which was a significant increase from previous year (4,000 cases in 2015). Furthermore, increasing number of approvals and launch of products by manufacturers such as Teva Pharmaceuticals USA, Inc.; Mylan N.V.; and Merck & Co., Inc.; are expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rise in investment by leading pharmaceutical companies for R&D on MDR tuberculosis drugs coupled with growing healthcare expenditure levels especially due to high prevalence rate of drug resistant TB across countries such as India & China & Indonesia etc.).
Growth Factors:
- Increasing incidence of bacterial infections: The increasing incidence of bacterial infections is one of the key growth drivers for the meropenem API market. This is because meropenem is an effective antibiotic against a wide range of bacteria.
- Rising demand for novel antibiotics: The rising demand for novel antibiotics is another key growth driver for the meropenem API market. This is because there are a limited number of new antibiotics in development, and meropenem has a good safety profile and broad spectrum activity against Gram-negative and Gram-positive bacteria.
- Growing prevalence of multidrug resistant bacteria: The growing prevalence of multidrug resistant bacteria is another key growth driver for the meropenem API market, as this increases the need for effective antibiotics such as meropenem that can combat these pathogens effectively.
- Increasing investment in R&D by pharmaceutical companies: Pharmaceutical companies are increasingly investing in R&D to develop new drugs, including antibacterial agents such as meropenem APIs. This will help to fuel the growth of the global Merpenam API market in coming years.. 5) Technological advancements: Technological advancements will also play a major role in drivinggrowthof themeropeenmAPImarketincomingyears,asnewandimproveddrugsolutionsaredevelopedbasedonthisplatform
Scope Of The Report
Report Attributes
Report Details
Report Title
Meropenem API Market Research Report
By Type
Crude Meropenem, Injection Grade Meropenem
By Application
Intravenous Injection, Intramuscular Injection
By Companies
ACS Dobfar, Savior Lifetec Corporation, Sumitomo Chemical Company, Shenzhen Haibin Pharmaceutical, Zhuhai United Laboratories, Zhejiang Hisun Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, Sun Pharma, Kopran, Hainan Haiyao, Zhejiang Hisoar, Kaliberr Labs, Jeil Pharmaceutical, Qilu Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Meropenem API Market Report Segments:
The global Meropenem API market is segmented on the basis of:
Types
Crude Meropenem, Injection Grade Meropenem
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Intravenous Injection, Intramuscular Injection
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ACS Dobfar
- Savior Lifetec Corporation
- Sumitomo Chemical Company
- Shenzhen Haibin Pharmaceutical
- Zhuhai United Laboratories
- Zhejiang Hisun Pharmaceutical
- Zhejiang Jiuzhou Pharmaceutical
- Sun Pharma
- Kopran
- Hainan Haiyao
- Zhejiang Hisoar
- Kaliberr Labs
- Jeil Pharmaceutical
- Qilu Pharmaceutical
Highlights of The Meropenem API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Crude Meropenem
- Injection Grade Meropenem
- By Application:
- Intravenous Injection
- Intramuscular Injection
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Meropenem API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Meropenem API is a platform that helps healthcare providers manage and monitor meropenem prescriptions. It provides real-time information about meropenem prescriptions, including drug dosage, patient demographics, and pharmacy data.
Some of the key players operating in the meropenem api market are ACS Dobfar, Savior Lifetec Corporation, Sumitomo Chemical Company, Shenzhen Haibin Pharmaceutical, Zhuhai United Laboratories, Zhejiang Hisun Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, Sun Pharma, Kopran, Hainan Haiyao, Zhejiang Hisoar, Kaliberr Labs, Jeil Pharmaceutical, Qilu Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Meropenem API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Meropenem API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Meropenem API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Meropenem API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Meropenem API Market Size & Forecast, 2020-2028
4.5.1 Meropenem API Market Size and Y-o-Y Growth
4.5.2 Meropenem API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Crude Meropenem
5.2.2 Injection Grade Meropenem
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Intravenous Injection
6.2.2 Intramuscular Injection
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Meropenem API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Meropenem API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Crude Meropenem
9.6.2 Injection Grade Meropenem
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Intravenous Injection
9.10.2 Intramuscular Injection
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Crude Meropenem
10.6.2 Injection Grade Meropenem
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Intravenous Injection
10.10.2 Intramuscular Injection
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Crude Meropenem
11.6.2 Injection Grade Meropenem
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Intravenous Injection
11.10.2 Intramuscular Injection
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Crude Meropenem
12.6.2 Injection Grade Meropenem
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Intravenous Injection
12.10.2 Intramuscular Injection
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Crude Meropenem
13.6.2 Injection Grade Meropenem
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Intravenous Injection
13.10.2 Intramuscular Injection
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Meropenem API Market: Competitive Dashboard
14.2 Global Meropenem API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ACS Dobfar
14.3.2 Savior Lifetec Corporation
14.3.3 Sumitomo Chemical Company
14.3.4 Shenzhen Haibin Pharmaceutical
14.3.5 Zhuhai United Laboratories
14.3.6 Zhejiang Hisun Pharmaceutical
14.3.7 Zhejiang Jiuzhou Pharmaceutical
14.3.8 Sun Pharma
14.3.9 Kopran
14.3.10 Hainan Haiyao
14.3.11 Zhejiang Hisoar
14.3.12 Kaliberr Labs
14.3.13 Jeil Pharmaceutical
14.3.14 Qilu Pharmaceutical
